Sanara MedTech (SMTI)
NASDAQ:SMTI
Earnings Data
Report Date
May 18, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.13Last Year’s EPS
-0.41Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call highlights strong commercial momentum and meaningful financial improvement in 2025 — including record revenue, expanded gross margins, materially higher adjusted EBITDA, a positive operating cash flow turnaround, distributor and facility expansion, Vizient contract win, and clear R&D/IP progress. Near-term headwinds include a Q4 continuing-operations net loss, a noncash impairment charge, higher operating expenses driven by strategic investments, a sizable increase in long-term debt, and THP wind-down cash impacts. Management reiterated confident, externally provided guidance for 2026 and plans targeted investments (sales coverage expansion, R&D) to support growth. Overall, the positive operational and financial achievements, plus tangible growth catalysts, outweigh the listed challenges.Company Guidance
Record-Breaking Full Year Revenue
Net revenue of $103.1M for full year 2025, the first time above $100M, representing 19% year-over-year growth.
Expanded Profitability Metrics
Full year gross margin expanded ~200 basis points to 93%; adjusted EBITDA improved by $7.9M or 86% to $17.0M; net loss from continuing operations improved by $1.5M (an ~80% reduction) year-over-year.
Positive Operating Cash Flow Turnaround
Generated $6.8M of cash provided by operating activities in 2025 versus $24,000 of cash used in operations in 2024 (note: the 2025 figure is inclusive of THP-related outflows).
Solid Q4 Revenue Performance (With Storm-Adjusted Growth)
Q4 2025 net revenue of $27.5M, up 5% year-over-year; excluding ~$1.8M of storm-driven BIASURGE sales in Q4 2024, Q4 2025 revenue grew ~13% year-over-year and came in at the high end of prior guidance.
Commercial Expansion — Distributor and Facility Growth
Distributor footprint expanded to over 450 contracted distributors from over 350 at end-2024 (≈+29%); sold into over 1,450 health care facilities at year-end 2025 versus >1,300 in 2024 (≈+11.5%); products contracted/approved in >4,000 facilities.
Strategic Vizient Contract for BIASURGE
BIASURGE awarded Vizient Innovative Technology contract effective Jan 1, 2026, providing access to ~1,800 Vizient facilities at contracted pricing — a major commercial distribution milestone that expands addressable accounts.
Clinical, IP and Pipeline Progress
Peer-reviewed support: BIASURGE showed high antimicrobial efficacy and low cytotoxicity; ALLOCYTE Plus demonstrated solid fusion outcomes in a 24–36 month study. Converted 11 provisional patent apps to nonprovisional and filed U.S. and PCT protections; added 3 new provisionals. OsStic remains on track for U.S. commercialization in Q1 2027 with preclinical bonding ~40x stronger than traditional cement.
Revenue Guidance and Forward Transparency
Management introduced and reaffirmed FY2026 net revenue guidance of $116M–$121M (≈13%–17% growth) and Q1 2026 guidance of $26.7M–$27.2M (≈14%–16% growth), signaling confidence and transparency on expected performance.
SMTI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SMTI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Mar 24, 2026 | $18.34 | $18.08 | -1.42% |
Nov 12, 2025 | $28.04 | $21.11 | -24.71% |
Aug 13, 2025 | $27.47 | $31.92 | +16.20% |
May 14, 2025 | $35.10 | $31.30 | -10.83% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sanara MedTech (SMTI) report earnings?
Sanara MedTech (SMTI) is schdueled to report earning on May 18, 2026, Before Open (Confirmed).
What is Sanara MedTech (SMTI) earnings time?
Sanara MedTech (SMTI) earnings time is at May 18, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SMTI EPS forecast?
SMTI EPS forecast for the fiscal quarter 2026 (Q1) is 0.13.